SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
This Quarter Return
+9.18%
1 Year Return
+29.51%
3 Year Return
+13.62%
5 Year Return
+117.76%
10 Year Return
+239.6%
AUM
$605M
AUM Growth
+$605M
(+26%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
16.7%
Top 10 Holdings %
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224
Top Buys
| 1 |
AbbVie
ABBV
|
$6.52M |
| 2 |
Incyte
INCY
|
$6.31M |
| 3 |
Teradyne
TER
|
$6.12M |
| 4 |
Delta Air Lines
DAL
|
$5.71M |
| 5 |
ResMed
RMD
|
$5.67M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$46.8M |
| 2 |
Carvana
CVNA
|
$8.46M |
| 3 |
Wynn Resorts
WYNN
|
$5.62M |
| 4 |
Apple
AAPL
|
$5.53M |
| 5 |
Novartis
NVS
|
$5.28M |
Sector Composition
| 1 | Technology | 21.71% |
| 2 | Consumer Discretionary | 17.11% |
| 3 | Healthcare | 15.75% |
| 4 | Industrials | 11.14% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Tyson Foods
TSN
$20.1B
| $777K | 0.13% |
+15,225
| New | +$777K |
|
227
Liberty Global Class A
LBTYA
$3.96B
| $758K | 0.13% |
44,939
+10,409
| +30% | +$175K |
|
228
Carnival PLC
CUK
$37.2B
| $753K | 0.12% |
+44,438
| New | +$753K |
|
229
Illinois Tool Works
ITW
$76.4B
| $750K | 0.12% |
+2,999
| New | +$750K |
|
230
Protagonist Therapeutics
PTGX
$3.66B
| $748K | 0.12% |
+27,092
| New | +$748K |
|
231
Pure Storage
PSTG
$25.3B
| $741K | 0.12% |
+20,117
| New | +$741K |
|
232
Gilead Sciences
GILD
$140B
| $735K | 0.12% |
+9,540
| New | +$735K |
|
233
Bloom Energy
BE
$12B
| $734K | 0.12% |
44,909
+30,046
| +202% | +$491K |
|
234
Teledyne Technologies
TDY
$25.2B
| $733K | 0.12% |
+1,782
| New | +$733K |
|
235
Murphy USA
MUSA
$7.19B
| $724K | 0.12% |
+2,327
| New | +$724K |
|
236
Cincinnati Financial
CINF
$23.9B
| $721K | 0.12% |
+7,413
| New | +$721K |
|
|
237
Carvana
CVNA
$50.6B
| $716K | 0.12% |
27,639
-326,409
| -92% | -$8.46M |
|
238
Skyworks Solutions
SWKS
$10.8B
| $711K | 0.12% |
+6,422
| New | +$711K |
|
239
Omnicom Group
OMC
$14.9B
| $707K | 0.12% |
+7,426
| New | +$707K |
|
240
Biohaven
BHVN
$1.68B
| $704K | 0.12% |
+29,443
| New | +$704K |
|
241
Louisiana-Pacific
LPX
$6.49B
| $702K | 0.12% |
+9,365
| New | +$702K |
|
242
Integra LifeSciences
IART
$1.18B
| $700K | 0.12% |
+17,017
| New | +$700K |
|
243
Edwards Lifesciences
EW
$48B
| $696K | 0.12% |
7,382
-20,930
| -74% | -$1.97M |
|
244
Delek US
DK
$1.86B
| $695K | 0.11% |
+29,013
| New | +$695K |
|
245
Premier
PINC
$2.14B
| $695K | 0.11% |
+25,112
| New | +$695K |
|
246
Nucor
NUE
$33.6B
| $694K | 0.11% |
4,235
+1,665
| +65% | +$273K |
|
247
Amcor
AMCR
$19.4B
| $694K | 0.11% |
69,522
+33,029
| +91% | +$330K |
|
248
Doximity
DOCS
$12.5B
| $694K | 0.11% |
+20,387
| New | +$694K |
|
249
Tenet Healthcare
THC
$16.4B
| $689K | 0.11% |
+8,472
| New | +$689K |
|
250
A.O. Smith
AOS
$9.86B
| $685K | 0.11% |
+9,406
| New | +$685K |
|